Anti-inflammatory Drug Algorithm for COVID-19 Home Treatment

NCT05249790 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped authorization denied

Conditions

COVID-19

Interventions

DRUG: Recommended treatment schedule
DRUG: Usual care

Sponsor

Mario Negri Institute for Pharmacological Research

Collaborators

[object Object]